derinet® Switzerland
Back

15.00% p.a. Barrier Reverse Convertible on Lonza, Novartis, Novavax (Quanto NZD)

  • Valor 113445967
  • ISIN CH1134459671
  • Symbol RMB61V
Bid (indicative)%
Nominal
Ask (indicative)%
Nominal
CurrencyNZD
Price on
Sell
Buy
  • Quanto
  • (Issuer) Callable
Novartis AGCHF 
Lonza Group AGCHF 
Novavax Inc.USD 
Please note that this is an indication.

Documents

Interest
Coupon (Coupon p.a.)22.50% (15.00%)
Premium component20.3754%
Interest share2.1246%
Day count convention30/360
Pricingdirty
Life cycle
Initial fixing22/10/2021
First Trading Day27/10/2021
Payment date28/10/2021
Final fixing24/04/2023
Redemption02/05/2023

Current price information

Intraday1 week1 monthyear to dateSince emission
until
Product Underlying

Loading data

Performance
UnderlyingClosing PriceStrike PriceBarrier
CHF 642.40CHF 755.00CHF 415.30
CHF 79.87CHF 77.54CHF 42.65
USD 90.36USD 134.56USD 74.01

No chart available

Interest
Coupon (Coupon p.a.)22.50% (15.00%)
Premium component20.3754%
Interest share2.1246%
Day count convention30/360
Pricingdirty
Life cycle
Initial fixing22/10/2021
First Trading Day27/10/2021
Payment date28/10/2021
Final fixing24/04/2023
Redemption02/05/2023
Figures
SSPA categorisationBarriere Reverse Convertible
Issue price100.00%
Nominal valueNZD 1,000.00
Reference currencyNZD
QuantoYes
Strike price

Reference price of the underlying used to calculate the cash settlement on expiry of the warrant. In cases of physical delivery it is the price at which the underlying is bought (call) or sold (put). Also called: exercise price

100.00%
Barrier55.00%
Barrier observationcontinuous
ListingSIX Structured Products Exchange
Additional conditions
IssuerVontobel Financial Products Ltd., DIFC Dubai
GuarantorVontobel Holding AG, Zurich
Lead ManagerBank Vontobel AG, Zurich
Redemption / deliverycash payment
Issuance ProgrammeLink to the Issuance Program